pubmed.ncbi.nlm.nih.gov

Multiple sclerosis: geoepidemiology, genetics and the environment - PubMed

️Invalid Date

Review

Multiple sclerosis: geoepidemiology, genetics and the environment

Ron Milo et al. Autoimmun Rev. 2010 Mar.

Abstract

Multiple sclerosis (MS) is a chronic immune-mediated demyelinating disease of the central nervous system characterized by relapses and remissions. The risk of acquiring this complex disease is associated with exposure to environmental factors in genetically susceptible individuals. The epidemiology of MS has been extensively studied. We review the geographic epidemiology of the disease, the influence of immigration, age at immigration, clustering and epidemics. Various presumptive risk factors are discussed such as ultraviolet radiation, vitamin D, Epstein-Barr virus and infectious mononucleosis, other infectious agents and non-infectious factors. Two different hypotheses, the hygiene hypothesis and the prevalence hypothesis, were proposed to explain these environmental risk factors for MS. The epidemiological data, combined with pathological and immunological data, may contribute to the debate whether MS is an autoimmune disease, a latent or persistent viral disease, or a neurodegenerative disease.

PubMed Disclaimer

Cited by

Central nervous system demyelinating diseases and recombinant hepatitis B vaccination: a critical systematic review of scientific production.
Martínez-Sernández V, Figueiras A. Martínez-Sernández V, et al. J Neurol. 2013 Aug;260(8):1951-9. doi: 10.1007/s00415-012-6716-y. Epub 2012 Oct 20. J Neurol. 2013. PMID: 23086181 Review.
Optimal combination of FLAIR and T2-weighted MRI for improved lesion contrast in multiple sclerosis.
Gabr RE, Hasan KM, Haque ME, Nelson FM, Wolinsky JS, Narayana PA. Gabr RE, et al. J Magn Reson Imaging. 2016 Nov;44(5):1293-1300. doi: 10.1002/jmri.25281. Epub 2016 Apr 29. J Magn Reson Imaging. 2016. PMID: 27126898 Free PMC article.
Socioeconomic determinants of global distribution of multiple sclerosis: an ecological investigation based on Global Burden of Disease data.
Moghaddam VK, Dickerson AS, Bazrafshan E, Seyedhasani SN, Najafi F, Hadei M, Momeni J, Moradi G, Sarmadi M. Moghaddam VK, et al. BMC Neurol. 2021 Apr 1;21(1):145. doi: 10.1186/s12883-021-02170-3. BMC Neurol. 2021. PMID: 33794796 Free PMC article.
Role of the P2 × 7 receptor in neurodegenerative diseases and its pharmacological properties.
Hu Z, Luo Y, Zhu J, Jiang D, Luo Z, Wu L, Li J, Peng S, Hu J. Hu Z, et al. Cell Biosci. 2023 Dec 13;13(1):225. doi: 10.1186/s13578-023-01161-w. Cell Biosci. 2023. PMID: 38093352 Free PMC article. Review.
Cost-effectiveness of different interferon beta products for relapsing-remitting and secondary progressive multiple sclerosis: Decision analysis based on long-term clinical data and switchable treatments.
Nikfar S, Kebriaeezadeh A, Dinarvand R, Abdollahi M, Sahraian MA, Henry D, Akbari Sari A. Nikfar S, et al. Daru. 2013 Jun 22;21(1):50. doi: 10.1186/2008-2231-21-50. Daru. 2013. PMID: 23800250 Free PMC article.

Multiple sclerosis: geoepidemiology, genetics and the environment - PubMed